Recent patents on immunoregulatory DNA vaccines for autoimmune diseases and allograft rejection

Recent Patents on DNA and Gene Sequences

Volumn 4, Issue 2, 2010, Pages 122-131

  Shabahang, Shahrokh ^a   Li, Alice F ^b   Escher, Alan ^b  

^a Sekris Corporation   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Autoimmune disease; Clinical trial; CpG dinucleotide; DNA vaccine; Immune tolerance; Inflammation; Molecular adjuvant; Organ transplantation; Rodent model system

Indexed keywords

AUTOANTIGEN; CYCLOPHOSPHAMIDE; DNA VACCINE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUTAMATE DECARBOXYLASE; GROWTH FACTOR; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; INSULIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; PLASMID DNA; PREPROINSULIN; PREPROINSULIN 1; PREPROINSULIN 2; PROTEIN BAX; RAPAMYCIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL TRIAL; CPG ISLAND; CYTOKINE RELEASE; DNA IMMUNIZATION; DNA MODIFICATION; DNA SEQUENCE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONSTRUCT; GENE TARGETING; GENETIC ENGINEERING; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; MICE; PATENTS AS TOPIC; TRANSPLANTATION, HOMOLOGOUS; VACCINES, DNA;

RODENTIA;

EID: 78649638994     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221510793205700     Document Type: Article

References (50)

1. Garren H. DNA vaccines for autoimmune diseases. Expert Rev Vaccines 2009; 8: 1195-203.
2. Bot A, Stan AC, Inaba K, Steinman R, Bona C. Dendritic cells at a DNA vaccination site express the encoded influenza nucleoprotein and prime MHC class I-restricted cytolytic lymphocytes upon adoptive transfer. Int Immunol 2000; 12: 825-32.
3. Corr M, von Damm A, Lee DJ, Tighe H. In vivo priming by DNA injection occurs predominantly by antigen transfer. J Immunol 1999; 163: 4721-7.
4. Lewis PJ, van Drunen lvdH, Babiuk LA. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol 1999; 73: 10214-23.
5. Li AF, Hough J, Henderson D, Escher A. Co-delivery of proapoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine 2004; 22: 1751-63.
6. Ferrera F, La Cava A, Rizzi M, Hahn BH, Indiveri F, Filaci G. Gene vaccination for the induction of immune tolerance. Ann N Y Acad Sci 2007; 1110: 99-111.
7. Li AF, Escher A. DNA vaccines for transplantation. Expert Opin Biol Ther 2010; 10: 903-15.
8. Karin N. Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines. Curr Opin Mol Ther 2004; 6: 27-33.
9. Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksenberg JR, Brocke S, et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med 1996; 2: 899-905.
10. Kumar V, Maglione J, Thatte J, Pederson B, Sercarz E, Ward ES. Induction of a type 1 regulatory CD4 T cell response following V beta 8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis. Int Immunol 2001; 13: 835-41.
11. Mauri C, Ehrenstein MR. Cells of the synovium in rheumatoid arthritis. B cells. Arthritis Res Ther 2007; 9: 205.
12. Von Herrath, M.G. Compositions and methods for the treatment or prevention of autoimmune diabetes. US6884785 (2005).
13. Coon B, An LL, Whitton JL, von Herrath MG. DNA immunization to prevent autoimmune diabetes. J Clin Invest 1999; 104: 189-94.
14. Escher, A.P., Liu, J. Methods of delaying the onset of diabetes. US6995147 (2006).
15. Filippova M, Liu J, Escher A. Effects of plasmid DNA injection on cyclophosphamide-accelerated diabetes in NOD mice. DNA Cell Biol 2001; 3: 175-81.
16. Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005; 23: 115-26.
17. Brode S, Raine T, Zaccone P, Cooke A. Cyclophosphamideinduced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol. 2006; 177: 6603-12.
18. Tisch R, Wang B, Weaver DJ, Liu B, Bui T, Arthos J, et al. Antigen- specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination. J Immunol 2001; 166: 2122-32.
19. Glinka Y, De Pooter R, Croze F, Prud'homme GJ. Regulatory cytokine production stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic mice. J Mol Med 2003; 81: 175-84.
20. Escher, A.P., Li, F. Substances for preventing and treating autoimmune diseases. US7381711 (2008).
21. Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A. Proapoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro. Vaccine 2006; 24: 5036-46.
22. Birge RB, Ucker DS. Innate apoptotic immunity: the calming touch of death. Cell Death Differ 2008; 15: 1096-102.
23. Steinman, L., Ruiz, P., Garren, H. DNA vaccination for treatment of autoimmune disease. US7030098 (2006).
24. Steinman, L., Ruiz, P., Garren, H. DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus. US7579328 (2009).
25. Fontura, P., Garren, H., Robinson, W.H., Steinman, L., Ruiz, P.J., Utz, P.J. Polynucleotide therapy. US7544669 (2009).
26. Ho PP, Fontoura P, Ruiz PJ, Steinman L, Garren H. An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems. J Immunol 2003; 171: 4920-6.
27. Cohen, I.R., Mimran, A., Quintana, F., Mor, F., Carmi, P. CD25 DNA vaccines for treating and preventing T-cell mediated diseases. US20070274949 (2007).
28. Mimran A, Mor F, Carmi P, Quintana FJ, Rotter V, Cohen IR. DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response. J Clin Invest 2004; 113: 924-32.
29. Schippling DS, Martin R. Spotlight on anti-CD25: daclizumab in MS. Int MS J 2008; 15: 94-8.
30. Escher, A.P., Li, F. Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders. US20080194510 (2008).
31. Nishira, J., Koyama, Y., Onodera, S. DNA vaccine. US20080247994 (2008).
32. Greven D, Leng L, Bucala R. Autoimmune diseases: MIF as a therapeutic target. Expert Opin Ther Targets 2010; 14: 253-64.
33. Wang, Q., Prud'homme, G.J., Kumar, M. Composition and method for prevention and treatment of type 1 diabetes. US20090016968 (2009).
34. Glinka Y, Chang Y, Prud'homme GJ. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand. Mol Ther 2006; 14: 578-87.
35. Cohen, I.R., Quintana, F.J., Carmi, P., Mor, F. DNA vaccines encoding heat shock proteins. US20090238864 (2009).
36. Cohen, I.R., Quintana, F. DNA vaccines encoding HSP60 peptide fragments for treating autoimmune diseases. US20090202618 (2009).
37. Garren, H., Leviten, M., Solvason, N. Polynucleotide therapy. US20100048679 (2010).
38. Bar-Or A, Vollmer T, Antel J, Arnold DL, Bodner CA, Campagnolo D, et al. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Arch Neurol 2007; 64: 1407-15.
39. Organ Procurement and Transplantation Network. Transplants in the U.S. by State. Available at: http://optn.transplant.hrsa.gov/latestData/rptData.asp. (Accessed on: April 19, 2010).
40. Gander B, Brown CS, Vasilic D, Furr A, Banis JC Jr, Cunningham M, et al. Composite tissue allotransplantation of the hand and face: a new frontier in transplant and reconstructive surgery. Transpl Int 2006; 19: 868-80.
41. Li A, Chen J, Hattori M, Franco E, Zuppan C, Ojogho O, et al. A therapeutic DNA vaccination strategy for autoimmunity and transplantation. Vaccine 2010; 28: 1897-904.
42. Birk OS, Gur SL, Elias D, Margalit R, Mor F, Carmi P, et al. The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci USA 1999; 96: 5159-63.
43. Fedoseyeva EV, Kishimoto K, Rolls HK, Illigens BM, Dong VM, Valujskikh A, et al. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol 2002; 169: 1168-74.
44. Yamada Y, Sekine Y, Yoshida S, Yasufuku K, Petrache I, Benson HL, et al. Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 2009; 183: 237-45.
45. Benichou G, Alessandrini A, Charrad RS, Wilkes DS. Induction of autoimmunity after allotransplantation. Front Biosci 2007; 12: 4362-9.
46. Li, F., Escher, A.P. DNA vaccines and methods for the prevention of transplantation rejection. US20090191218 (2009).
47. Ito K, Tanaka K, Nishibe Y, Hasegawa J, Ueno H. GABAsynthesizing enzyme, GAD67, from dermal fibroblasts: evidence for a new skin function. Biochim Biophys Acta 2007; 1770: 291-6.
48. Valujskikh A, Fedoseyeva E, Benichou G, Heeger PS. Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation 2002; 73: 1130-7.
49. Peachman KK, Rao M, Alving CR. Immunization with DNA through the skin. Methods 2003; 31: 232-42.
50. Solvason N, Lou YP, Peters W, Evans E, Martinez J, Ramirez U, et al. Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sites. J Immunol 2008; 181: 8298-307.